corporate overview - bilcare
TRANSCRIPT
![Page 1: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/1.jpg)
Speed | Innovation | HappinessCorporate Overview
![Page 2: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/2.jpg)
Speed | Innovation | Happiness
Contents
2
Bilcare Overview
Businesses
Business Strategy
Financial Overview
![Page 3: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/3.jpg)
Speed | Innovation | Happiness 3
Bilcare Overview
![Page 4: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/4.jpg)
Speed | Innovation | Happiness
Vision
Delivering Innovation – Transforming Lives
Speed Innovation Happiness
Proactive and swift action is our mantra
Our constant approach at all levels is to seek better ways of listening, thinking and doing - making our offerings meaningful and
impactful
We are motivated by our customer's success and
happiness of our stakeholders.
4
Values
Our ObjectiveBilcare Overview
![Page 5: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/5.jpg)
Speed | Innovation | Happiness 5
Business Overview
Market position
Leading provider of Research
based Innovative packaging solutions
Revenues
USD 550 million in revenues
Customers
Over 2500 customers globally
Global Footprint
Plants in 13 locations across Europe, US and
Asia
People
Team of 2300 strong
professionals globally
Bilcare Overview
![Page 6: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/6.jpg)
Speed | Innovation | Happiness 6
Delaware, USA
Staufen, Germany
Bötzingen, GermanyWeißandt-Gölzau, Germany
Fucine, Italy
Castglione, Italy
Thane, India
Nasik, India
Crickhowel, UK
Singapore
Phoenixville, USA
Tampa, USA
Pune, India
Global PresenceBilcare Overview
![Page 7: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/7.jpg)
Speed | Innovation | Happiness
Corporate Structure
Bilcare India
Bilcare Singapore
100%
Bilcare Inc.
100%
Bilcare U.K.
100%
Bilcare Clinical Supplies (Europe) Ltd.
100%
Bilcare Brazil
100%
Bilcare Technologies
80%
Bilcare Technologies Italia
92%
International Labs
50%
Bilcare Mauritius
100%
Bilcare AG
100%
Bilcare Research GmbH
100%
Caprihans
51%
Bilcare Italia Srl. 100%
Bilcare Films Italia Srl.
100%
Bilcare Research Inc.
100%
Bilcare Overview
7
![Page 8: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/8.jpg)
Speed | Innovation | Happiness
Businesses
8
![Page 9: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/9.jpg)
Speed | Innovation | Happiness
Business Verticals
9
Bilcare Solutions
Pharma Packaging Innovations
Packaging Films Solutions
Cards Solutions
Specialty Films Solutions
Global Clinical Supplies
Accelerating drug development process –
Solutions for Clinical Trial Programs; facilitating speed
to market
nonClonableIDTM
Technologies
Anytime, Anywhere Authentication and Track-and-Trace technology for
people and products
Businesses
![Page 10: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/10.jpg)
Speed | Innovation | Happiness
Bilcare Solutions
Pharma Packaging Innovations
Packaging Films Solutions
Cards Solutions
Specialty Films Solutions
Pioneers in providing a wide range of pharmaceutical films & foils, to suit the sensitivity of the drug and strengthen its brand equity
High quality cores and overlays for all kind of cards for Banking, Mobile, Loyalty, Club Memberships, Casinos etc.
Leading suppliers of wide range of rigid Mono and Multilayer films for Food & FMCG industry
High quality Films for sectors such as Printing/ Decoration, Shrink films, Visual packaging, Technical applications, Office materials and Furniture
10
Businesses
![Page 11: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/11.jpg)
Speed | Innovation | Happiness 11
Bilcare GCS provides: Protocol design Regulatory compliance & patient safety Batch manufacturing Packaging design Clinical packaging and randomization Storage and global distribution Returns management
Distinctive services to customers in the area of product formulation and development Opportunity to more rapidly and effectively conduct clinical trials,
thereby enhancing the speed to market of pharmaceutical products
Global Clinical Supplies
End-to-end clinical supplies management services; facilitating speed to market
Businesses
![Page 12: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/12.jpg)
Speed | Innovation | Happiness 12
Wide range of Applications
Security & ID Cards Document Security Currency Security Pharmaceutical Medical Compliance Agrochemicals High-value components Fashion & Luxury goods
nonClonableIDTM Benefits
Better visibility throughout the supply chain
Reliable brand and asset protection Real-time authentication Efficient Inventory management Prevents product diversion and
entry of fake products in the supply chain
nonClonableIDTM
Technologies
Anytime, Anywhere Authentication and Track-and-Trace technology for people and products.
Businesses
![Page 13: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/13.jpg)
Speed | Innovation | Happiness 13
How is it made? How does it work?
nonClonableIDTM
Technologies
Authentication and Track ‘n’ Trace Anytime, Anywhere
Businesses
![Page 14: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/14.jpg)
Speed | Innovation | Happiness 14
Business Strategy
![Page 15: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/15.jpg)
Speed | Innovation | Happiness
Addressing Challenges
Regulatory hurdles
R&D and Innovation pipeline deficit
Lack of patient population for enrollment
Global Clinical Supplies
Brand Protection
Lack of Authentication tools
Revenue & Profit leakages
Security threats
nonClonableIDTM
Technologies
Compliance
Counterfeit
Communication
Convenience
Cost
Bilcare Packaging Solutions
15
Business Strategy
![Page 16: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/16.jpg)
Speed | Innovation | Happiness 16
Financial Overview
![Page 17: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/17.jpg)
Speed | Innovation | Happiness 17
Particulars
31.03.2009 31.03.2010 31.03.2011
Audited (12 months)
Audited (12 months)
Audited(12 months)
Revenue (Including other Income) 863.73 1065.80 2328.82
Contribution 389.36 474.71 1023.95
% of Revenue 45.08% 44.54% 43.97%
Fixed Expenses 195.14 214.80 647.03
EBITDTA 194.22 259.91 376.92
% of revenue 22.49% 24.39% 16.19%
Interest 39.26 43.89 91.75
Depreciation 37.84 53.55 85.91
PBT 117.12 162.47 199.25
Tax 34.18 45.52 49.79
PAT 82.94 116.95 149.46
Crores
Profit & Loss StatementFinancial Overview
![Page 18: Corporate Overview - Bilcare](https://reader030.vdocuments.us/reader030/viewer/2022012509/6186c05496912c2cc164634c/html5/thumbnails/18.jpg)
Speed | Innovation | Happiness 18
Balance Sheet
Particulars31.03.2009 31.03.2010 31.03.2011
Audited Audited Audited
Equity capital 17.21 22.69 23.55
Net worth (including deferred tax) 577.15 967.12 1248.32
Debt 950.46 599.32 1219.73
Total 1544.82 1589.13 2491.60
Net Fixed Assets 844.35 887.91 1443.92
Investments 145.46 0.00 0.23
Net Current Assets 531.49 673.99 1023.18
Misc. Expenses 23.52 27.23 24.27
Total 1544.82 1589.13 2491.60
Financial Overview
Crores